Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Common Equity (2016 - 2025)

Historic Common Equity for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $1.8 billion.

  • Prestige Consumer Healthcare's Common Equity rose 229.35% to $1.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.8 billion, marking a year-over-year increase of 229.35%. This contributed to the annual value of $1.8 billion for FY2025, which is 1086.43% up from last year.
  • As of Q4 2025, Prestige Consumer Healthcare's Common Equity stood at $1.8 billion, which was up 229.35% from $1.8 billion recorded in Q3 2025.
  • Prestige Consumer Healthcare's 5-year Common Equity high stood at $1.9 billion for Q2 2025, and its period low was $1.4 billion during Q1 2021.
  • Over the past 5 years, Prestige Consumer Healthcare's median Common Equity value was $1.6 billion (recorded in 2022), while the average stood at $1.6 billion.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Common Equity surged by 1614.62% in 2022, and later tumbled by 827.37% in 2023.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Common Equity stood at $1.5 billion in 2021, then grew by 11.1% to $1.7 billion in 2022, then fell by 5.12% to $1.6 billion in 2023, then grew by 11.74% to $1.8 billion in 2024, then rose by 2.29% to $1.8 billion in 2025.
  • Its Common Equity was $1.8 billion in Q4 2025, compared to $1.8 billion in Q3 2025 and $1.9 billion in Q2 2025.